Powerful health care companies shape the informational environments around their products. As part of this playbook, companies avoid or thwart the generation and dissemination of accurate information on the true value of their products. Consequently, Americans spend too much on health care with dubious or even negative value.

The logic of the Court's recent TransUnion decision should make it harder, perhaps impossible, for corporations to enforce various forms of so-called “intellectual property” against competitors and the public. Could and should the legal left wield TransUnion for our own purposes?